Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO study.
Bergen ES, Pilla L, Auclin E, Ilhan-Mutlu A, Prager GW, Pietrantonio F, Antista M, Ghelardi F, Basile D, Aprile G, Longarini R, Hautefeuille V, Tougeron D, Artru P, Mabro M, Drouillard A, Roth G, Ben Abdelghani M, Clement I, Toullec C, Mineur L, Guimbaud R, Taieb J, Zaanan A. Bergen ES, et al. Gastric Cancer. 2023 May;26(3):425-437. doi: 10.1007/s10120-023-01374-5. Epub 2023 Mar 7. Gastric Cancer. 2023. PMID: 36881202
Brain metastases from hepatopancreatobiliary malignancies.
Bergen ES, Friedrich A, Scherleitner P, Ferreira P, Kiesel B, Widhalm G, Kiesewetter B, Eckert F, Prager GW, Preusser M, Berghoff AS. Bergen ES, et al. Clin Exp Metastasis. 2023 Apr;40(2):177-185. doi: 10.1007/s10585-023-10201-1. Epub 2023 Mar 22. Clin Exp Metastasis. 2023. PMID: 36947280 Free PMC article.
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study.
Gallois C, Bergen ES, Auclin É, Pernot S, Higué J, Trouilloud I, Touchefeu Y, Turpin A, Mazard T, Sartore-Bianchi A, Prenen H, Alberti A, Pilla L, Cuissy S, Wookey V, Perret A, Melchior C, Artru P, Dubreuil O, Drouillard A, Doat S, Lavolé J, Basile D, Perkins G, Jary M, Stintzing S, Ros J, Tougeron D, Taieb J. Gallois C, et al. Among authors: bergen es. ESMO Open. 2024 Sep;9(9):103696. doi: 10.1016/j.esmoop.2024.103696. Epub 2024 Sep 9. ESMO Open. 2024. PMID: 39255538 Free PMC article.
Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma.
Tomasich E, Mühlbacher J, Wöran K, Hatziioannou T, Herac M, Kleinberger M, Berger JM, Dibon LK, Berchtold L, Heller G, Bergen ES, Macher-Beer A, Prager G, Schindl M, Preusser M, Berghoff AS. Tomasich E, et al. Among authors: bergen es. Transl Res. 2024 Sep;271:40-51. doi: 10.1016/j.trsl.2024.05.005. Epub 2024 May 9. Transl Res. 2024. PMID: 38734064 Free article.
Malignant ascites: Current therapy options and treatment prospects.
Berger JM, Preusser M, Berghoff AS, Bergen ES. Berger JM, et al. Among authors: bergen es. Cancer Treat Rev. 2023 Oct 24;121:102646. doi: 10.1016/j.ctrv.2023.102646. Online ahead of print. Cancer Treat Rev. 2023. PMID: 39492370 Free article. Review.
Correction to: Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort.
Puhr HC, Berchtold L, Zingerle L, Felfernig M, Weissenbacher L, Jomrich G, Asari R, Schoppmann SF, Prager GW, Bergen ES, Berghoff AS, Preusser M, Ilhan-Mutlu A. Puhr HC, et al. Among authors: bergen es. Wien Klin Wochenschr. 2024 Oct 18. doi: 10.1007/s00508-024-02456-9. Online ahead of print. Wien Klin Wochenschr. 2024. PMID: 39422753 No abstract available.
Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort.
Puhr HC, Berchtold L, Zingerle L, Felfernig M, Weissenbacher L, Jomrich G, Asari R, Schoppmann SF, Prager GW, Bergen ES, Berghoff AS, Preusser M, Ilhan-Mutlu A. Puhr HC, et al. Among authors: bergen es. Wien Klin Wochenschr. 2024 Sep 5. doi: 10.1007/s00508-024-02432-3. Online ahead of print. Wien Klin Wochenschr. 2024. PMID: 39235615
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases.
Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Mair MJ, Starzer AM, Forstner H, Rottenmanner B, Aretin MB, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Pfeiler G, Singer C, Weltermann A, Berchtold L, Preusser M. Bartsch R, et al. Among authors: bergen es. Neuro Oncol. 2024 Dec 5;26(12):2305-2315. doi: 10.1093/neuonc/noae123. Neuro Oncol. 2024. PMID: 38963808 Free PMC article. Clinical Trial.
Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center.
Popov P, Steindl A, Wolff L, Bergen ES, Eckert F, Frischer JM, Widhalm G, Fuereder T, Raderer M, Berghoff AS, Preusser M, Kiesewetter B. Popov P, et al. Among authors: bergen es. Clin Exp Metastasis. 2024 Feb;41(1):25-32. doi: 10.1007/s10585-023-10250-6. Epub 2023 Dec 8. Clin Exp Metastasis. 2024. PMID: 38064128 Free PMC article.
21 results